English

SEU Annual report for 2023 including annexes

This evaluation report summarises key learning around MSF-Germany’s (MSF-G) strategic plan (SP) (2021-2024) to improve and inform decisions, support resource allocation and inform strategic priorities for MSF-G’s 2025-2029 SP. This evaluation was commissioned by the MSF-G general director (GD) and head of strategy and planning, and completed by Standard of Proof, in collaboration with the MSF Vienna Evaluation Unit (VEU).

At the request of the authorities and the Alex Ekwueme Federal University Teaching Hospital of
Abakaliki (AE-FUTHA), a team from Médecins Sans Frontières (MSF) - Operational Centre Brussels
(OCB) supported AE-FUTHA’s response to the outbreak in Ebonyi State. This emergency intervention
led to an interest in having a longer-term project to continue to support the Lassa fever response and
build institutional capacity for this neglected disease. As a result, a four-year project in Abakaliki
started end of 2018 and was later extended until 2025.

In order to improve the relevance, effectiveness and quality of its interventions, MSF, decided to conduct an
evaluation of the Abakaliki project from its onset until the end of 2022.

Despite declining TB notifications in Southern Africa, TB-related deaths
remain high. We describe patient- and population-level trends in TB-related deaths in Eswatini over a period of 11 years.

Improving The Availability & Use of SGBV Services in Kananga Project in Central Kasai, DRC
- Phase 2 Evaluation report (in English and French)

The Global Health Actors Network (GHAN) is made up of people working directly, or with an interest, in global health issues and actors within MSF. The network provides analysis and guidance on advocacy strategies, as a facilitator rather than a gatekeeper. It aims to improve information sharing and support for staff that interact with these actors and initiatives, and to improve MSFs understanding of the global health landscape and health policy trends.

The Field Recentralization Programme’s design, implementation and outcomes was the focus of the evaluation commissioned by OCB’s General Director and Director of Operations based on the work completed in Central and Southern Africa. A consultation group representing the Regional Support Groups in the Southern African Region and Central Afrixa, Middle-Eastern countries, catalyst team and OCB Board accompanied the evaluation.

The evaluation was implemented by an evaluation team led by Amjad Idries and managed by the SEU. Recommendations focused on suggestions that could enhance the programme design and implementation in the next phase, looking at, amongst other areas: Leadership, Governance, and Oversight; Programme implementation guidance and communication; and Implementation Monitoring and Evaluation. Download the full report below in English or the translated version in French. 

As of 2020, there were an estimated 57 million people chronically infected with Hepatitis C virus (HCV) globally, with around 10% of these living in Pakistan. OCB has run an HCV project in Machar Colony Karachi since 2015. In 2020, the strategy for 2021-2024 was revised to build on the success and capitalize on earlier experience. This evaluation was conducted with the purpose to reflect and take stock of this revised strategic direction and the likelihood of its success within the given context.

This evaluation has a specific focus on lessons learned about the design and implementation of the school-based component of the Eshowe TB programme, conditions for success, enablers and challenges to identify considerations for replicability should MSF decide to implement a similar programme elsewhere in South Africa, or internationally.

This evaluation focuses on the basic clinical nursing care (BCNC) training initiative implemented by the Médecins Sans Frontières (MSF) Academy in Kenema, Sierra Leone since 2020 and in Old Fangak (OFG), South Sudan since 2021. The evaluation specifically covers the first implementation of BCNC in these locations to the point of the graduation of the first cohort of nurses in May/June 2022. The specific stated purpose of the evaluation was to assess the value of the BCNC programme in Kenema and OFG. Ultimately key stakeholders wanted to know which results the BCNC has achieved, if they are worth the investment and if potential adaptations could increase the value of the BCNC.